Not every person experiencing treatment-resistant depression responds to traditional antidepressants, and that reality can be isolating and discouraging. If you have tried multiple medications without finding relief, SPRAVATO® treatment may represent a meaningful new direction in your care. At Precise Mind, with offices in Flowood, Vicksburg, and Ridgeland, our team dedicates itself to helping you explore all available options on your path toward improved mental health.
SPRAVATO® (esketamine) is an FDA-cleared nasal spray used alongside an oral antidepressant to address treatment-resistant depression in adults. A provider must administer it in a certified healthcare setting and provide direct supervision afterward, meaning you can not take it home. We are a certified SPRAVATO® treatment site, offering a safe and monitored environment for every session. You can speak with our team of psychiatrists to learn more about this option if you are asking yourself, "Who can benefit from SPRAVATO® treatment in Ridgeland?"
Treatment-resistant depression is a form of Major Depressive Disorder (MDD), in which a person has not experienced adequate relief after trying at least two different antidepressant medications at appropriate doses and durations.
Research has shown that with each subsequent round of medication, the likelihood of achieving remission decreases, and the chance of discontinuing treatment increases due to a rise in common side effects (Rush et al., 2006). If this pattern sounds familiar, you may benefit from exploring SPRAVATO® as a treatment option in Ridgeland.
The FDA approved SPRAVATO® specifically for adults with treatment-resistant depression and for adults with MDD who have active suicidal ideation with intent or behavior and would benefit from more intensive treatment. A thorough evaluation at our office will help determine whether you meet the clinical criteria for this treatment. During this process, our providers will review your psychiatric history, the medications you have previously tried, and your current behavioral health condition. Being open and thorough during this conversation gives our team the information we need to build the most appropriate plan for you.
Individuals with a history of specific cardiovascular conditions, aneurysmal vascular disease, or a personal or family history of psychosis should not take SPRAVATO®. Our SPRAVATO® team will discuss these considerations with you carefully and answer any questions you may have about the benefits, safety profile, and more before treatment in Ridgeland begins.
SPRAVATO® sessions take place at our office, where you will self-administer the nasal spray under medical supervision. Following each session, your provider will observe you for a minimum of two hours before giving you clearance to leave. Because of this monitoring period, you will need to arrange for someone to drive you home after each appointment. We typically schedule sessions twice per week for the first month, then gradually taper them based on your response and your provider's recommendations.
Individual responses vary, but some people in Ridgeland report improvements within the first few weeks of consistent SPRAVATO® treatment. Our team will monitor your progress closely and adjust your care plan as needed throughout the process.
If you or someone you love has been living with depression that has not responded to standard treatments, SPRAVATO® could offer a promising new option.
At Precise Mind, our providers take a compassionate, individualized approach to every patient's care. Call us today to schedule an appointment and get answers to your questions if you are asking yourself, "Who can benefit from SPRAVATO treatment in Ridgeland?"